Drugs / monoclonal factor IX concentrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00004801 | Mar 1992 → ? | hemophilia B | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | monoclonal factor IX concentrate | “Assess the safety and long-term efficacy of monoclonal factor IX concentrate in patients with factor IX deficiency.” NCT00004801 ↗ |